|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
affects expression |
EXP |
Naproxen affects the expression of ABCB1 mRNA |
CTD |
PMID:18581209 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases activity |
EXP |
Naproxen inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Naproxen results in decreased activity of ABCB11 protein |
CTD |
PMID:24014644 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
affects expression affects activity |
EXP |
Naproxen affects the expression of ABCG2 protein Naproxen affects the activity of ABCG2 protein |
CTD |
PMID:18581209 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
decreases expression |
EXP |
Naproxen results in decreased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
Naproxen results in increased expression of ADIPOQ protein |
CTD |
PMID:23784744 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AKR1C1 |
aldo-keto reductase family 1 member C1 |
decreases activity |
EXP |
Naproxen results in decreased activity of AKR1C1 protein |
CTD |
PMID:19010312 |
|
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
decreases activity |
EXP |
Naproxen results in decreased activity of AKR1C2 protein |
CTD |
PMID:19010312 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
decreases activity |
EXP |
Naproxen results in decreased activity of AKR1C3 protein |
CTD |
PMID:19010312 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
ALB |
albumin |
affects binding |
EXP ISO |
[Naproxen binds to Cobalt] which binds to ALB protein; Naproxen binds to ALB protein |
CTD |
PMID:9353694 PMID:22178666 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
BACE1 |
beta-secretase 1 |
decreases expression |
ISO |
Naproxen results in decreased expression of BACE1 mRNA |
CTD |
PMID:16407166 |
|
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of BDNF protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of BDNF protein] |
CTD |
PMID:22150557 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL20 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL20 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL22 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL22 protein] |
CTD |
PMID:22150557 |
|
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL3 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL3 protein] |
CTD |
PMID:22150557 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
EXP |
Naproxen inhibits the reaction [TNF protein results in increased expression of CCND1 protein] |
CTD |
PMID:15489888 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCR4 |
C-C motif chemokine receptor 4 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCR4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CCR4 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
|
|
G |
CD80 |
CD80 molecule |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] affects the reaction [Capsaicin results in increased expression of CD80 protein]; Naproxen affects the reaction [Capsaicin results in increased expression of CD80 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CILK1 |
ciliogenesis associated kinase 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CILK1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CILK1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 6:53,001,303...53,061,824
Ensembl chr 6:53,001,279...53,061,824
|
|
G |
CNTF |
ciliary neurotrophic factor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CNTF protein] |
CTD |
PMID:22150557 |
|
NCBI chr11:58,622,665...58,625,733
Ensembl chr11:58,622,665...58,625,733
|
|
G |
CNTFR |
ciliary neurotrophic factor receptor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CNTFR protein] |
CTD |
PMID:22150557 |
|
NCBI chr 9:34,551,433...34,590,852
Ensembl chr 9:34,551,432...34,590,140
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCR4 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
multiple interactions increases metabolic processing decreases methylation affects metabolic processing |
EXP |
Amiodarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen]; Benzbromarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen]; Dapsone promotes the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen]; Dapsone promotes the reaction [CYP2C9 protein results in decreased methylation of Naproxen] CYP2C9 protein results in increased metabolism of Naproxen CYP2C9 protein polymorphism results in decreased methylation of Naproxen; CYP2C9 protein results in decreased methylation of Naproxen CYP2C9 gene polymorphism affects the metabolism of Naproxen; CYP2C9 protein affects the metabolism of Naproxen |
CTD |
PMID:11901091 PMID:12464242 PMID:15130760 PMID:16081671 PMID:17681167 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP4A11 |
cytochrome P450 family 4 subfamily A member 11 |
affects activity |
EXP |
Naproxen affects the activity of CYP4A11 protein |
CTD |
PMID:37499995 |
|
NCBI chr 1:46,929,188...46,941,476
Ensembl chr 1:46,929,177...46,941,484
|
|
G |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of ERRFI1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:8,011,727...8,026,309
Ensembl chr 1:8,004,404...8,026,309
|
|
G |
FADD |
Fas associated via death domain |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FADD protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FADD protein] |
CTD |
PMID:22150557 |
|
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FAS protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FAS protein] |
CTD |
PMID:22150557 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FASLG protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FGFBP1 |
fibroblast growth factor binding protein 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of FGFBP1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 4:15,935,577...15,938,740
Ensembl chr 4:15,935,577...15,938,740
|
|
G |
FGL1 |
fibrinogen like 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FGL1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FGL1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 8:17,864,389...17,895,538
Ensembl chr 8:17,864,380...17,910,365
|
|
G |
FSTL1 |
follistatin like 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of FSTL1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 3:120,392,293...120,450,992
Ensembl chr 3:120,392,293...120,451,016
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression |
EXP |
Naproxen results in increased expression of GCLC mRNA |
CTD |
PMID:11909699 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression |
EXP |
Naproxen results in increased expression of GCLM mRNA |
CTD |
PMID:11909699 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GFRA1 |
GDNF family receptor alpha 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of GFRA1 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of GFRA1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
|
|
G |
GFRA2 |
GDNF family receptor alpha 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of GFRA2 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of GFRA2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 8:21,690,398...21,812,345
Ensembl chr 8:21,690,398...21,812,357
|
|
G |
GH1 |
growth hormone 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of GH1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of GH1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
|
|
G |
GHR |
growth hormone receptor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of GHR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of GHR protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878
|
|
G |
HCRT |
hypocretin neuropeptide precursor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of HCRT protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of HCRT protein] |
CTD |
PMID:22150557 |
|
NCBI chr17:42,184,060...42,185,452
Ensembl chr17:42,184,060...42,185,452
|
|
G |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
affects expression |
EXP |
Naproxen affects the expression of HLA-DMB mRNA |
CTD |
PMID:25811541 |
|
NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028
|
|
G |
IDE |
insulin degrading enzyme |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IDE protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of IDE protein] |
CTD |
PMID:22150557 |
|
NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in decreased expression of IFNG protein]; Naproxen inhibits the reaction [Capsaicin results in decreased expression of IFNG protein] |
CTD |
PMID:22150557 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL10 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL10 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL13 |
interleukin 13 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL13 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL13 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in decreased expression of IL1A protein]; Naproxen inhibits the reaction [Capsaicin results in decreased expression of IL1A protein] |
CTD |
PMID:22150557 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP ISO |
Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]; Naproxen promotes the reaction [Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Dinoprostone]]; Naproxen promotes the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Dinoprostone]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IL1B protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of IL1B protein] |
CTD |
PMID:14762100 PMID:15705740 PMID:22150557 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL3 |
interleukin 3 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of IL3 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of IL3 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
|
|
G |
IL4 |
interleukin 4 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL4 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL5 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL5 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of IL6 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of IL6 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INHBA |
inhibin subunit beta A |
multiple interactions |
ISO |
Naproxen inhibits the reaction [Capsaicin results in increased expression of INHBA protein] |
CTD |
PMID:22150557 |
|
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions increases expression |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of INS1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of INS1 protein] Naproxen results in increased expression of INS1 protein |
CTD |
PMID:22150557 PMID:23784744 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
LEP |
leptin |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of LEP protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of LEP protein] |
CTD |
PMID:22150557 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
MIF |
macrophage migration inhibitory factor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MIF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MIF protein] |
CTD |
PMID:22150557 |
|
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MMP13 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MMP13 protein] |
CTD |
PMID:22150557 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MMP2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MMP2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
EXP |
[Hydrogen Peroxide results in increased activity of MPO protein] which results in increased oxidation of and results in increased susceptibility to Naproxen |
CTD |
PMID:28754375 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MUSK |
muscle associated receptor tyrosine kinase |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of MUSK protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of MUSK protein] |
CTD |
PMID:22150557 |
|
NCBI chr 9:110,668,791...110,806,558
Ensembl chr 9:110,668,779...110,806,558
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
Naproxen inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Naproxen inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] |
CTD |
PMID:15489888 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NGF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of NGF protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NGFR |
nerve growth factor receptor |
increases expression multiple interactions |
EXP ISO |
Naproxen results in increased expression of NGFR protein [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NGFR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of NGFR protein] |
CTD |
PMID:17409433 PMID:22150557 |
|
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
|
|
G |
NOS2 |
nitric oxide synthase 2 |
increases expression |
ISO |
Naproxen results in increased expression of NOS2 mRNA |
CTD |
PMID:16944022 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NRP1 |
neuropilin 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
|
|
G |
PDGFA |
platelet derived growth factor subunit A |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PDGFA protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PDGFA protein] |
CTD |
PMID:22150557 |
|
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
|
|
G |
PLIN2 |
perilipin 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of PLIN2 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of PLIN2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290
|
|
G |
POMC |
proopiomelanocortin |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of POMC protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of POMC protein] |
CTD |
PMID:22150557 |
|
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
increases activity |
ISO |
Naproxen results in increased activity of PPARA protein |
CTD |
PMID:11755111 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
increases activity |
ISO |
Naproxen results in increased activity of PPARG protein |
CTD |
PMID:11755111 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PRKAA1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRLR |
prolactin receptor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PRLR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PRLR protein] |
CTD |
PMID:22150557 |
|
NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487
|
|
G |
PROK1 |
prokineticin 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of PROK1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of PROK1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:110,451,149...110,457,358
Ensembl chr 1:110,451,149...110,457,358
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
decreases activity |
EXP ISO |
Naproxen results in decreased activity of PTGS1 protein |
CTD |
PMID:9258749 PMID:17164136 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases activity increases expression |
EXP ISO |
Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]; Naproxen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] Naproxen results in decreased activity of PTGS2 protein Naproxen results in increased expression of PTGS2 |
CTD |
PMID:9258749 PMID:11840453 PMID:15489888 PMID:15705740 PMID:17164136 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Naproxen inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Naproxen inhibits the reaction [TNF protein results in increased activity of RELA protein] |
CTD |
PMID:15489888 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REN |
renin |
decreases activity |
EXP |
Naproxen results in decreased activity of REN protein |
CTD |
PMID:2203262 |
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RETN |
resistin |
multiple interactions decreases expression |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of RETN protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of RETN protein] Naproxen results in decreased expression of RETN protein |
CTD |
PMID:22150557 PMID:23784744 |
|
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
|
|
G |
RETNLB |
resistin like beta |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of RETNLB protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of RETNLB protein] |
CTD |
PMID:22150557 |
|
NCBI chr 3:108,755,638...108,757,410
Ensembl chr 3:108,743,424...108,757,410
|
|
G |
SELE |
selectin E |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SELE protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of SELE protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
|
|
G |
SELL |
selectin L |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SELL protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of SELL protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
|
|
G |
SLC22A11 |
solute carrier family 22 member 11 |
decreases activity |
EXP |
Naproxen results in decreased activity of SLC22A11 protein |
CTD |
PMID:12388633 |
|
NCBI chr11:64,555,941...64,572,875
Ensembl chr11:64,555,690...64,572,875
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
decreases activity |
EXP |
Naproxen results in decreased activity of SLC22A2 protein |
CTD |
PMID:12388633 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SLC22A6 |
solute carrier family 22 member 6 |
decreases activity |
EXP |
Naproxen results in decreased activity of SLC22A6 protein |
CTD |
PMID:12388633 |
|
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
|
|
G |
SLC22A7 |
solute carrier family 22 member 7 |
decreases activity |
EXP |
Naproxen results in decreased activity of SLC22A7 protein |
CTD |
PMID:12388633 |
|
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
|
|
G |
SLC22A9 |
solute carrier family 22 member 9 |
decreases activity |
EXP |
Naproxen results in decreased activity of SLC22A9 protein |
CTD |
PMID:12388633 |
|
NCBI chr11:63,369,785...63,410,294
Ensembl chr11:63,369,785...63,410,294
|
|
G |
SLCO2A1 |
solute carrier organic anion transporter family member 2A1 |
multiple interactions |
EXP |
Naproxen promotes the reaction [SLCO2A1 protein results in increased transport of Dinoprostone] |
CTD |
PMID:19843975 |
|
NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of SPP1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of SPP1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
TAL1 |
TAL bHLH transcription factor 1, erythroid differentiation factor |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TAL1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TAL1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:47,216,290...47,232,335
Ensembl chr 1:47,216,290...47,232,225
|
|
G |
TEK |
TEK receptor tyrosine kinase |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TEK protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TEK protein] |
CTD |
PMID:22150557 |
|
NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TGFB1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TGFB3 |
transforming growth factor beta 3 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TGFB3 protein] |
CTD |
PMID:22150557 |
|
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TIMP1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TIMP2 protein] |
CTD |
PMID:22150557 |
|
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
|
|
G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TIMP3 protein] |
CTD |
PMID:22150557 |
|
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TLR4 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TLR4 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TMPRSS2 |
transmembrane serine protease 2 |
increases expression |
EXP |
Naproxen results in increased expression of TMPRSS2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP ISO |
Naproxen inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Naproxen inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Naproxen inhibits the reaction [TNF protein results in increased activity of RELA protein]; Naproxen inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Naproxen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNF protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TNF protein] |
CTD |
PMID:15489888 PMID:22150557 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF19 |
TNF receptor superfamily member 19 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein]; Naproxen inhibits the reaction [Capsaicin affects the expression of TNFRSF19 protein] |
CTD |
PMID:22150557 |
|
NCBI chr13:23,570,412...23,676,093
Ensembl chr13:23,570,370...23,676,104
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases activity increases glucuronidation |
EXP |
Naproxen results in decreased activity of UGT1A1 protein UGT1A1 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:15593333 PMID:15843492 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:15535975 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
increases glucuronidation |
EXP |
UGT1A3 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:15535975 PMID:15843492 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
increases glucuronidation |
EXP |
UGT1A6 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:15843492 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
EXP |
UGT1A9 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:15535975 |
|
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
UGT2B17 |
UDP glucuronosyltransferase family 2 member B17 |
increases glucuronidation |
ISO |
UGT2B1 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:8302279 |
|
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
|
|
G |
UGT2B4 |
UDP glucuronosyltransferase family 2 member B4 |
increases glucuronidation |
EXP |
UGT2B4 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:15843492 |
|
NCBI chr 4:69,480,165...69,526,014
Ensembl chr 4:69,480,165...69,526,014
|
|
G |
UGT2B7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions increases glucuronidation |
EXP |
Naproxen inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Naproxen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone] UGT2B7 protein alternative form results in increased glucuronidation of Naproxen; UGT2B7 protein results in increased glucuronidation of Naproxen |
CTD |
PMID:8423545 PMID:8517101 PMID:15535975 PMID:15843492 PMID:19740398 |
|
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of VCAM1 protein] |
CTD |
PMID:22150557 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
ISO |
[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of VEGFA protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of VEGFA protein] |
CTD |
PMID:22150557 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|